BIONTECH SE's ticker is BNTX and the CUSIP is 09075V102. A total of 38 filers reported holding BIONTECH SE in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $63,088,335 | +2.5% | 580,710 | +1.8% | 0.01% | 0.0% |
Q2 2023 | $61,544,708 | -48.5% | 570,228 | -40.5% | 0.01% | -53.8% |
Q1 2023 | $119,401,342 | +77.1% | 958,508 | +113.5% | 0.01% | +62.5% |
Q4 2022 | $67,429,401 | +46.8% | 448,871 | +31.8% | 0.01% | +33.3% |
Q3 2022 | $45,944,000 | +12.2% | 340,627 | +24.0% | 0.01% | +20.0% |
Q2 2022 | $40,957,000 | -18.8% | 274,696 | -7.1% | 0.01% | -28.6% |
Q1 2022 | $50,427,000 | -31.7% | 295,661 | +3.3% | 0.01% | -22.2% |
Q4 2021 | $73,811,000 | -19.2% | 286,315 | -14.4% | 0.01% | -25.0% |
Q3 2021 | $91,361,000 | +27.3% | 334,667 | +4.4% | 0.01% | +33.3% |
Q2 2021 | $71,770,000 | +37.9% | 320,572 | -32.8% | 0.01% | +12.5% |
Q1 2021 | $52,061,000 | +106.6% | 476,797 | +54.2% | 0.01% | +100.0% |
Q4 2020 | $25,204,000 | +266.5% | 309,171 | +211.2% | 0.00% | +300.0% |
Q3 2020 | $6,877,000 | +344.3% | 99,336 | +328.1% | 0.00% | – |
Q2 2020 | $1,548,000 | +94.0% | 23,205 | +70.0% | 0.00% | – |
Q1 2020 | $798,000 | +1713.6% | 13,652 | +933.5% | 0.00% | – |
Q4 2019 | $44,000 | – | 1,321 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bill & Melinda Gates Foundation | 148,674 | $16,151,943 | 19.26% |
Quinn Opportunity Partners LLC | 659,383 | $71,635,369 | 9.22% |
Systrade AG | 50,000 | $5,432,000 | 4.70% |
Crocodile Capital Partners GmbH | 29,586 | $3,214,223 | 3.03% |
ALTRINSIC GLOBAL ADVISORS LLC | 700,421 | $76,093,737 | 2.94% |
Temasek Holdings (Private) Ltd | 4,518,080 | $490,844,211 | 2.92% |
PARUS FINANCE (UK) Ltd | 25,662 | $2,787,920 | 1.74% |
FLOSSBACH VON STORCH AG | 3,513,215 | $381,675,678 | 1.68% |
AtonRa Partners | 4,707 | $511,368 | 1.07% |
Baader Bank Aktiengesellschaft | 135,093 | $14,617,456 | 0.99% |